Triple-negative breast cancer molecular subtyping and treatment progress

Triple-negative breast cancer molecular subtyping and treatment progress

Abstract Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), has clinical features that include high invasiveness, high metastatic potential, proneness...

Full description

Bibliographic Details
Main Authors: Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-cang Yu
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Breast Cancer Research
Subjects:
Triple-negative breast cancer
Molecular subtype
Therapeutic target
Therapeutic regimen
Online Access:http://link.springer.com/article/10.1186/s13058-020-01296-5

Internet

http://link.springer.com/article/10.1186/s13058-020-01296-5

Similar Items